CD226 and neoplasm: In oral squamous cell carcinoma (OSCC), SPP1+ tumor-associated macrophages (TAMs) activate fibroblasts via SPP1-CD44 signaling and induce T cell exhaustion by promoting the ubiquitination and degradation of CD226 on T cells through CD155-CD226 signaling.